Janssen Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Janssen Pharmaceuticals, Inc.
Quantité totale PI 441
Quantité totale incluant filiales 531 (+ 90 pour les filiales)
Rang # Quantité totale PI 2 996
Note d'activité PI 3,2/5.0    291
Rang # Activité PI 2 453
Activité incl filiales 2,9/5.0    295
Parent Johnson & Johnson
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

212 0
74 0
154 0
1
 
Dernier brevet 2025 - Esketamine for the treatment of ...
Premier brevet 1981 - Pre-filled syringe for abusable ...
Dernière marque 2019 - SUVRILO
Première marque 2019 - SUVRILO

Filiales

3 subsidiaries with IP (90 patents, 0 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Pure forms of crystalline aticaprant. The disclosure provides compositions containing pure atica...
Invention Compositions of phosphorylated tau peptides and uses thereof. Liposomes containing tau peptides,...
Invention Method of safe administration of phosphorylated tau peptide vaccine. Methods for inducing anti-p...
Invention Fimh mutants, compositions therewith and use thereof. Polypeptides comprising a FimH lectin doma...
Invention Controlling operation of drug administration devices using surgical hubs. In general, systems an...
Invention Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, an...
Invention Mdr e. coli immunogen. The subject relates to an isolated antibody that specifically binds to O2...
Invention Compositions comprising aticaprant. The present disclosure relates to compositions, including or...
Invention Multivalent vaccine compositions and uses thereof. Compositions and methods are described for in...
Invention Liposomes containing phosphorylated tau peptides for inducing sustained immune responses. Method...
2024 Invention Forms of aticaprant. The disclosure provides crystalline and amorphous forms of aticaprant. Also...
Invention Esketamine for the treatment of depression. The present invention provides methods of maintainin...
Invention Mono- or di-substituted indole derivatives as dengue viral replication inhibitors. The present i...
Invention Compositions and methods for the treatment of depression. The disclosure provides methods for tre...
Invention Anti-respiratory syncytial virus antibodies and uses thereof. Provided herein are antibodies and ...
Invention Systems and methods for sterilizing mass flow meters and their use for precise pharmaceutical con...
Invention Tau active functional assays. The application describes methods for evaluating the capacity of an...
Invention Method of treating preclinicial alzheimer's disease. The application describes a phosphorylated t...
Invention Method of treating preclinicial alzheimer's disease. The application describes a phosphorylated ...
Invention Compositions comprising aticaprant for use in treating major depressive disorder. The present dis...
Invention Method for quantifying bound acetate in glycoconjugates. The present invention relates to a metho...
Invention Intranasal administration of esketamine. The present invention is directed to pharmaceutical pro...
Invention Forms of aticaprant. The disclosure provides crystalline and amorphous forms of aticaprant. Also ...
Invention Fimh mutant, compositions therewith and use thereof. Polypeptides comprising a FimH lectin domain...
Invention Compositions comprising aticaprant. The present disclosure relates to compositions, including ora...
Invention Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of...
2023 Invention Bioconjugate compositions and process for bioconjugate production. The present invention relates ...
Invention Multivalent vaccine compositions and uses thereof. Compositions and methods are described for ind...
Invention Expec glycoconjugate vaccine formulations. Compositions and methods for inducing an immune respo...
Invention Compositions and methods for enhancing gene expression. The present disclosure generally relates...
Invention Mono- or di-substituted indole derivatives as dengue viral replication inhibitors. The present in...
Invention Treatment or prevention of dengue viral infection. The present invention relates to a compound o...
Invention Vial holder. Various exemplary methods. systems. and devices for vial holders are provided. The ...
Invention Smart liquid drug administration. In general, devices, systems, and methods of smart liquid drug...
Invention Compositions and methods for the treatment of depression. The disclosure provides methods for tr...
2022 Invention Anti-human vista antibodies and use thereof. The invention provides antagonistic and agonistic a...
Invention Method of safe administration of tau phosphopeptide conjugate. Methods for inducing anti-phospho...
Invention Processes for the preparation of (s)-2-(4-chloro-2-methoxyphenyl)-2-((3 -methoxy-5-(m ethylsulfon...
Invention Single vial holder
Invention Dual vial holder
Invention Process for bioconjugate production. The present invention relates to a process for the producti...
Invention Staphylococcus aureus vaccine compositions. The present disclosure relates to immunogenic compos...
2021 Invention Stabilized coronavirus spike protein fusion proteins. The present invention provides stabilized ...
2020 Invention Drug delivery adjustment. Provided herein are drug administration devices, methods, and systems ...
2019 P/S Pharmaceutical preparations, in particular for the treatment of multiple sclerosis.